Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
PET devices have assorted applications across different clinical strengths. They are generally utilized in oncology for malignant growth organizing, treatment arranging, and observing restorative reaction. Moreover, PET assumes a vital part in cardiology, nervous system discipline, and psychiatry, extending its clinical impression and driving market interest.
The incorporation of PET with other imaging modalities, like computed tomography (CT) and magnetic resonance imaging (X-ray), is a prominent pattern. Combination imaging frameworks give both physical and useful data in a single output, improving symptomatic precision and working with additional thorough evaluations. This combination lines up with the pattern toward customized and exact medication.
PET depends on the utilization of radiopharmaceuticals for imaging, and progressing headways in this field add to the development of the PET devices market. Novel radiotracers with improved focusing on capacities empower the representation of explicit organic cycles, taking into consideration prior and more precise illness location.
Innovative work endeavours assume a critical part in forming the market elements. Coordinated efforts between industry players, academic foundations, and research associations add to the improvement of state-of-the-art PET advances and radiotracers, encouraging development and market development.
PET is acquiring conspicuousness in nervous system science for imaging cerebral blood stream, glucose digestion, and neuroreceptor restricting. Applications in neurodegenerative issues, like Alzheimer's illness, add to the broadening of PET gadget use and market extension.
The rising prevalence of persistent illnesses, including disease, cardiovascular issues, and neurological conditions, drives the interest for cutting edge demonstrative devices like PET. The capacity of PET devices to give practical and metabolic data supplements conventional imaging strategies, adding to extensive illness management.
The reception of consolidated PET/CT and PET/X-ray frameworks is on the rise. These incorporated frameworks offer the advantages of both physical and useful imaging, working on indicative precision and patient results. The adaptability of mixture imaging arrangements adds to their rising presence in clinical practice.
Positron Emission Tomography Devices Market Highlights:
Global Positron Emission Tomography Devices Market Overview
The global Positron Emission Tomography Devices Market size is expected to grow at CAGR of 6.5% to reach USD 1.06 Billion during the forecasted 2023-2032.
Contrast media injectors are medical devices utilized to inject CM into the body to enhance the visibility of tissues for different medical imaging procedures. These procedures include computed tomography, magnetic resonance imaging, positron emission tomography, or magnetic resonance. CM injectors find extensive applications in radiology, interventional cardiology, ambulatory surgical centers, and diagnostic imaging centers across the globe. They have evolved from simple, manual injectors to automated injectors that precisely control the amount of the CM agent used, facilitate automated data collection, and warn about potential hazards, such as air embolisms or extravasations.
Some of the factors driving the market growth include the increasing demand for PET analysis in radiopharmaceuticals and the integration of X-ray tomography into PET. According to the World Nuclear Association April 2021, around 10,000 hospitals use radioisotopes in medicine worldwide, and about 90% of the procedures are for diagnosis. As per the same source, in developed countries, the frequency of diagnostic nuclear medicine is 1.9% per year, and the frequency of therapy with radioisotopes is about one-tenth.
June 2024: Siemens Healthineers, a prominent medical equipment company, has obtained permission from the US Food and Drug Administration (FDA) for its Biograph Trinion PET/CT scanner. The PET/CT scanner incorporates a novel air-cooled, digital detector that utilizes lutetium oxyorthosilicate (LSO) crystal components.
The Biograph Trinion is a unified platform that combines PET, CT, and post-processing operations into a single device, with a time of flight (TOF) of 239 picoseconds (ps). Siemens Healthineers has announced that their integrated post-processing imaging applications encompass oncology, theranostics (a fusion of diagnostics and therapies for the identification and treatment of certain types of cancer), cardiovascular imaging, and neurology imaging (including Alzheimer's disease).
Positron Emission Tomography Devices Market Segment Insights
The positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.
Positron Emission Tomography Devices Product Type Insights
The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.
Positron Emission Tomography Devices Application Insights
The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and others.
Positron Emission Tomography Devices End User Insights
Based on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others. The hospitals segment is anticipated to hold the largest market share owing to the increasing cases of cancer. The diagnostic centres are expected to grow at the highest CAGR owing to the rising demand for early diagnosis.
Positron Emission Tomography Devices Regional Insights
In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.
The positron emission tomography devices (PET) market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European positron emission tomography devices (PET) market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The positron emission tomography devices (PET) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The positron emission tomography devices (PET) market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region. As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.
Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as, growing cases of head and neck cancer, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.
On the other hand, the Middle East and Africa held least share in the global positron emission tomography devices (PET) market due to the low per capita income, especially within the African region.
Positron Emission Tomography Devices Market Top Key Players
Some of the key players in the global positron emission tomography devices (PET) market are
- Agfa Healthcare
- Gamma Medica Inc.
- GE Healthcare
- Neusoft Medical Systems
- Oncovision
- Koninklijke Philips N.V.
- Positron Corporation
- Siemens AG
- Segami Corporation
- Spectrum Dynamics Ltd.
- Naviscan, Inc.
- MedX Holdings Inc.
- Modus Medical Devices Inc.
- Radiology Oncology Systems, Inc.
- Yangzhou Kindsway Biotech Co. Ltd.
- Toshiba Corporation
- Hitachi, Ltd.
Research Methodology
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
- Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
- Secondary Research
Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the Positron Emission Tomography Devices (PET). It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.
Recent Development
May 2021
In May 2021, GE Healthcare strengthened its PET imaging portfolio with the acquisition of Zionexa, a prominent innovator of in vivo oncology and neurology biomarkers that help enable more personalized healthcare. Thus, the above factors are expected to drive market growth. However, factors such as the shorter half-life of radioisotopes and stringent regulatory guidelines are expected to impede market growth in the near future.
November 2020
According to a research study by Adeline N. Boettcher et al., published in Radiology Imaging Cancer in November 2020, the postponement of routine screening examinations is expected to result in delays in new cancer diagnoses.
Intended Audience
- Medical Device Companies
- Government and Private Laboratories
- Research and Development (R&D) companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
Positron Emission Tomography Devices Market Segmentation
Positron Emission Tomography Devices (PET) Product Type Outlook
- Full Ring PET Scanners
- Partial Ring PET Scanners
Positron Emission Tomography Devices (PET) Applications Outlook
- Cardiology
- Neurology
- Oncology
- Orthopedics
- Urology
- Gastroenterology
- Othe
- Others
Positron Emission Tomography Devices (PET) End User Outlook
- Hospitals
- Clinics
- Diagnostic Centers
- Others
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
